Royal Bank of Canada’s Tarsus Pharmaceuticals TARS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $202K | Sell |
|
|||||
|
2025
Q2 | $7.68M | Buy |
|
|||||
|
2025
Q1 | $158K | Sell |
|
|||||
|
2024
Q4 | $194K | Sell |
|
|||||
|
2024
Q3 | $220K | Buy |
|
|||||
|
2024
Q2 | $170K | Buy |
|
|||||
|
2024
Q1 | $119K | Sell |
|
|||||
|
2023
Q4 | $267K | Buy |
|
|||||
|
2023
Q3 | $111K | Buy |
|
|||||
|
2023
Q2 | $50K | Buy |
|
|||||
|
2023
Q1 | $16K | Sell |
|
|||||
|
2022
Q4 | $43K | Buy |
|
|||||
|
2022
Q3 | $8K | Buy |
|
|||||
|
2022
Q2 | $4K | Sell |
|
|||||
|
2022
Q1 | $13K | Sell |
|
|||||
|
2021
Q4 | $49K | Buy |
|
|||||
|
2021
Q3 | $20K | Buy |
|
|||||
|
2021
Q2 | $17K | Sell |
|
|||||
|
2021
Q1 | $48K | Buy |
|
|||||
|
2020
Q4 | $34K | Buy |
|